Teerapat Ungtrakul
Teerapat Ungtrakul
Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy
Verified email at pccms.ac.th
TitleCited byYear
Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis
YH Yeo, HJ Ho, HI Yang, TC Tseng, T Hosaka, HN Trinh, MS Kwak, ...
Gastroenterology 156 (3), 635-646. e9, 2019
142019
Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial
T Sriprayoon, C Mahidol, T Ungtrakul, P Chun‐on, K Soonklang, ...
Hepatology Research 47 (3), E161-E168, 2017
122017
Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients
T Ungtrakul, T Sriprayoon, P Kusuman, P Chunnuan, K Soonklang, ...
Medicine 96 (13), 2017
102017
Andrographis paniculata: Dissolution investigation and pharmacokinetic studies of four major active diterpenoids after multiple oral dose administration in healthy Thai volunteers
N Pholphana, D Panomvana, N Rangkadilok, T Suriyo, P Puranajoti, ...
Journal of ethnopharmacology 194, 513-521, 2016
72016
A simple and sensitive LC-MS/MS method for determination of four major active diterpenoids from Andrographis paniculata in human plasma and its application to a pilot study
N Pholphana, D Panomvana, N Rangkadilok, T Suriyo, T Ungtrakul, ...
Planta medica 82 (01/02), 113-120, 2016
72016
Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area
T Ungtrakul, C Mahidol, P Chun-On, C Laohapand, S Siripongsakun, ...
World journal of gastroenterology 22 (34), 7806, 2016
52016
A phase Ib/II open label study of IMU-131 HER2/Neu peptide vaccine plus cisplatin and either 5-fluorouracil or capecitabine chemotherapy in patients with HER2/Neu …
U Wiedermann, AJ Good, E Garner-Spitzer, Y Chao, I Bulat, ...
Journal of Clinical Oncology 37 (4_suppl), TPS176-TPS176, 2019
22019
Clinical parameters following multiple oral dose administration of a standardized Andrographis paniculata capsule in healthy Thai subjects
T Suriyo, N Pholphana, T Ungtrakul, N Rangkadilok, D Panomvana, ...
Planta medica 83 (09), 778-789, 2017
22017
Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis
S Chujan, T Suriyo, T Ungtrakul, Y Pomyen, J Satayavivad
Biomedical Reports 9 (1), 42-52, 2018
12018
Efficacy of Trastuzumab in HERZ-Positive Early Breast Cancer in Thai Patients: A Single Institution Experience
P Patanayindee, K Soonklang, T Ungtrakul
Journal of the Medical Association of Thailand 101 (6), 101, 2018
12018
Human papillomavirus (HPV) in young patients with head and neck squamous cell carcinoma.
T Ungtrakul, S Keelawat, C Vinayanuwattikun, V Sriuranpong
Journal of Clinical Oncology 31 (15_suppl), e17004-e17004, 2013
12013
150P A Phase Ib Study of IMU-131 HER2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or …
Y Chao, M Maglakelidze, LV Bulat, T Yau, S Tanasanvimon, ...
Annals of Oncology 30 (Supplement_9), mdz422. 027, 2019
2019
397P Development of prediction model for hepatocellular carcinoma in chronic hepatitis B patients
T Ungtrakul, K Soonklang, J Dechma, P Kusuman, W Pongpun
Annals of Oncology 30 (Supplement_9), mdz432. 006, 2019
2019
1212P Comprehensive results of a phase Ib study with a HER2/neu B-cell peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy show safety …
U Wiedermann, E Garner-Spitzer, Y Chao, I Bulat, A Dechaphunkul, ...
Annals of Oncology 30 (Supplement_5), mdz253. 038, 2019
2019
A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety, immunogenicity …
U Wiedermann, E Garner-Spitzer, Y Chao, I Bulat, A Dechaphunkul, ...
CANCER RESEARCH 79 (13), 2019
2019
A phase 1b study of IMIJ-131 her2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or …
M Maglakelidze, T Yau, I Bulat, C Yen, Y Chao, L Bai, A Good, N Ede, ...
ANNALS OF ONCOLOGY 30, 123-123, 2019
2019
SO-004 A phase 1b study of IMU-131 her2/neu peptide vaccine plus chemotherapy in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or …
M Maglakelidze, T Yau, I Bulat, C Yen, Y Chao, L Bai, A Good, N Ede, ...
Annals of Oncology 30 (Supplement_4), mdz157. 003, 2019
2019
Abstract CT059: A Phase Ib open label multicenter study with a HER2/neu peptide vaccine administered with cisplatin and 5-fluorouracil or capecitabine chemotherapy shows safety …
U Wiedermann, E Garner-Spitzer, Y Chao, I Bulat, A Dechaphunkul, ...
Cancer Research 79 (13 Supplement), CT059-CT059, 2019
2019
A COMPARISON OF RISK SCORE MODELS TO PREDICT THE RISK OF HCC IN CHRONIC HEPATITIS B PATIENTS IN THAILAND: IDDF2019-ABS-0051
T Kamalapirat, T Ungtrakul, K Soonklang, J Dechma, P Chunnuan, ...
Gut 68, 2019
2019
IDDF2019-ABS-0051 A comparison of risk score models to predict the risk of HCC in chronic hepatitis b patients in thailand
T Kamalapirat, T Ungtrakul, K Soonklang, J Dechma, P Chunnuan, ...
Gut 68 (Suppl 1), A126-A126, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20